Lixte Biotechnology Holdings, Inc.
NASDAQ:LIXT · NASDAQ Capital Market
+$0.46 today
Vol 0.89M · Avg 0.12M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+866.23%
Period High
$7.61
Period Low
$0.71
Latest
$7.61
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Cingulate Inc.
CING
$28.65M
Allarity Therapeutics, Inc.
ALLR
$23.07M
Entero Therapeutics, Inc.
ENTO
$13.58M
Rocket One Inc.
HOTH
$13.52M
Lexaria Bioscience Corp.
LEXX
$12.27M
Kairos Pharma, Ltd.
KAPA
$9.69M
BriaCell Therapeutics Corp.
BCTX
$5.46M
Pulmatrix, Inc.
PULM
$5.30M
CASI Pharmaceuticals, Inc.
CASI
$2.33M
Clearside Biomedical, Inc.
CLSD
$2.15M
What is the latest LIXT filing?
The latest filing shown is 8-K dated Jun 16, 2026.
How many recent filings does LIXT have?
Intrinsic Alpha currently shows 20 recent filings for LIXT.
Explore More
Continue the stock analysis
Jump to another research area for this company.